Atlas Trials

Assessment of the Safety and Efficacy of RGN-259 Ophthalmic Solutions for Dry Eye Syndrome : ARISE-2

Clinical trial NCT02974907 · COMPLETED

Trial details

NCT number
NCT02974907
Sponsor
ReGenTree, LLC
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Dry Eye Syndrome
Start date
2016-11-01
Primary completion
2017-09-01
Enrollment
601

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.